Global Semi-Solid Formulations Drug Delivery Market Research Report 2024

Report ID: 1866782 | Published Date: Dec 2025 | No. of Page: 103 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Semi-Solid Formulations Drug Delivery Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Creams
        1.2.3 Ointments
        1.2.4 Lotions
        1.2.5 Gel
        1.2.6 Pastes
    1.3 Market by Application
        1.3.1 Global Semi-Solid Formulations Drug Delivery Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Home Care Settings
        1.3.3 Hospitals & Clinics
        1.3.4 Burn Centers
        1.3.5 Other Facilities
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Semi-Solid Formulations Drug Delivery Market Perspective (2017-2028)
    2.2 Semi-Solid Formulations Drug Delivery Growth Trends by Region
        2.2.1 Semi-Solid Formulations Drug Delivery Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Semi-Solid Formulations Drug Delivery Historic Market Size by Region (2017-2022)
        2.2.3 Semi-Solid Formulations Drug Delivery Forecasted Market Size by Region (2023-2028)
    2.3 Semi-Solid Formulations Drug Delivery Market Dynamics
        2.3.1 Semi-Solid Formulations Drug Delivery Industry Trends
        2.3.2 Semi-Solid Formulations Drug Delivery Market Drivers
        2.3.3 Semi-Solid Formulations Drug Delivery Market Challenges
        2.3.4 Semi-Solid Formulations Drug Delivery Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Semi-Solid Formulations Drug Delivery Players by Revenue
        3.1.1 Global Top Semi-Solid Formulations Drug Delivery Players by Revenue (2017-2022)
        3.1.2 Global Semi-Solid Formulations Drug Delivery Revenue Market Share by Players (2017-2022)
    3.2 Global Semi-Solid Formulations Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Semi-Solid Formulations Drug Delivery Revenue
    3.4 Global Semi-Solid Formulations Drug Delivery Market Concentration Ratio
        3.4.1 Global Semi-Solid Formulations Drug Delivery Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Semi-Solid Formulations Drug Delivery Revenue in 2021
    3.5 Semi-Solid Formulations Drug Delivery Key Players Head office and Area Served
    3.6 Key Players Semi-Solid Formulations Drug Delivery Product Solution and Service
    3.7 Date of Enter into Semi-Solid Formulations Drug Delivery Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Semi-Solid Formulations Drug Delivery Breakdown Data by Type
    4.1 Global Semi-Solid Formulations Drug Delivery Historic Market Size by Type (2017-2022)
    4.2 Global Semi-Solid Formulations Drug Delivery Forecasted Market Size by Type (2023-2028)
5 Semi-Solid Formulations Drug Delivery Breakdown Data by Application
    5.1 Global Semi-Solid Formulations Drug Delivery Historic Market Size by Application (2017-2022)
    5.2 Global Semi-Solid Formulations Drug Delivery Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Semi-Solid Formulations Drug Delivery Market Size (2017-2028)
    6.2 North America Semi-Solid Formulations Drug Delivery Market Size by Country (2017-2022)
    6.3 North America Semi-Solid Formulations Drug Delivery Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Semi-Solid Formulations Drug Delivery Market Size (2017-2028)
    7.2 Europe Semi-Solid Formulations Drug Delivery Market Size by Country (2017-2022)
    7.3 Europe Semi-Solid Formulations Drug Delivery Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Semi-Solid Formulations Drug Delivery Market Size (2017-2028)
    8.2 Asia-Pacific Semi-Solid Formulations Drug Delivery Market Size by Country (2017-2022)
    8.3 Asia-Pacific Semi-Solid Formulations Drug Delivery Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Semi-Solid Formulations Drug Delivery Market Size (2017-2028)
    9.2 Latin America Semi-Solid Formulations Drug Delivery Market Size by Country (2017-2022)
    9.3 Latin America Semi-Solid Formulations Drug Delivery Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size (2017-2028)
    10.2 Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size by Country (2017-2022)
    10.3 Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Glenmark Pharmaceuticals
        11.1.1 Glenmark Pharmaceuticals Company Detail
        11.1.2 Glenmark Pharmaceuticals Business Overview
        11.1.3 Glenmark Pharmaceuticals Semi-Solid Formulations Drug Delivery Introduction
        11.1.4 Glenmark Pharmaceuticals Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022)
        11.1.5 Glenmark Pharmaceuticals Recent Development
    11.2 Galderma
        11.2.1 Galderma Company Detail
        11.2.2 Galderma Business Overview
        11.2.3 Galderma Semi-Solid Formulations Drug Delivery Introduction
        11.2.4 Galderma Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022)
        11.2.5 Galderma Recent Development
    11.3 Johnson & Johnson Private
        11.3.1 Johnson & Johnson Private Company Detail
        11.3.2 Johnson & Johnson Private Business Overview
        11.3.3 Johnson & Johnson Private Semi-Solid Formulations Drug Delivery Introduction
        11.3.4 Johnson & Johnson Private Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022)
        11.3.5 Johnson & Johnson Private Recent Development
    11.4 GlaxoSmithKline
        11.4.1 GlaxoSmithKline Company Detail
        11.4.2 GlaxoSmithKline Business Overview
        11.4.3 GlaxoSmithKline Semi-Solid Formulations Drug Delivery Introduction
        11.4.4 GlaxoSmithKline Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022)
        11.4.5 GlaxoSmithKline Recent Development
    11.5 Bausch Health Companies
        11.5.1 Bausch Health Companies Company Detail
        11.5.2 Bausch Health Companies Business Overview
        11.5.3 Bausch Health Companies Semi-Solid Formulations Drug Delivery Introduction
        11.5.4 Bausch Health Companies Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022)
        11.5.5 Bausch Health Companies Recent Development
    11.6 Hisamitsu Pharmaceuticals
        11.6.1 Hisamitsu Pharmaceuticals Company Detail
        11.6.2 Hisamitsu Pharmaceuticals Business Overview
        11.6.3 Hisamitsu Pharmaceuticals Semi-Solid Formulations Drug Delivery Introduction
        11.6.4 Hisamitsu Pharmaceuticals Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022)
        11.6.5 Hisamitsu Pharmaceuticals Recent Development
    11.7 Cipla
        11.7.1 Cipla Company Detail
        11.7.2 Cipla Business Overview
        11.7.3 Cipla Semi-Solid Formulations Drug Delivery Introduction
        11.7.4 Cipla Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022)
        11.7.5 Cipla Recent Development
    11.8 Bayer
        11.8.1 Bayer Company Detail
        11.8.2 Bayer Business Overview
        11.8.3 Bayer Semi-Solid Formulations Drug Delivery Introduction
        11.8.4 Bayer Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022)
        11.8.5 Bayer Recent Development
    11.9 Viatris
        11.9.1 Viatris Company Detail
        11.9.2 Viatris Business Overview
        11.9.3 Viatris Semi-Solid Formulations Drug Delivery Introduction
        11.9.4 Viatris Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022)
        11.9.5 Viatris Recent Development
    11.10 3M
        11.10.1 3M Company Detail
        11.10.2 3M Business Overview
        11.10.3 3M Semi-Solid Formulations Drug Delivery Introduction
        11.10.4 3M Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022)
        11.10.5 3M Recent Development
    11.11 Merck & Co
        11.11.1 Merck & Co Company Detail
        11.11.2 Merck & Co Business Overview
        11.11.3 Merck & Co Semi-Solid Formulations Drug Delivery Introduction
        11.11.4 Merck & Co Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022)
        11.11.5 Merck & Co Recent Development
    11.12 Crescita Therpeautics
        11.12.1 Crescita Therpeautics Company Detail
        11.12.2 Crescita Therpeautics Business Overview
        11.12.3 Crescita Therpeautics Semi-Solid Formulations Drug Delivery Introduction
        11.12.4 Crescita Therpeautics Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022)
        11.12.5 Crescita Therpeautics Recent Development
    11.13 Novartis International
        11.13.1 Novartis International Company Detail
        11.13.2 Novartis International Business Overview
        11.13.3 Novartis International Semi-Solid Formulations Drug Delivery Introduction
        11.13.4 Novartis International Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022)
        11.13.5 Novartis International Recent Development
    11.14 Boehringer Ingelheim
        11.14.1 Boehringer Ingelheim Company Detail
        11.14.2 Boehringer Ingelheim Business Overview
        11.14.3 Boehringer Ingelheim Semi-Solid Formulations Drug Delivery Introduction
        11.14.4 Boehringer Ingelheim Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022)
        11.14.5 Boehringer Ingelheim Recent Development
    11.15 Pfizer
        11.15.1 Pfizer Company Detail
        11.15.2 Pfizer Business Overview
        11.15.3 Pfizer Semi-Solid Formulations Drug Delivery Introduction
        11.15.4 Pfizer Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022)
        11.15.5 Pfizer Recent Development
    11.16 Teva Pharmaceuticals
        11.16.1 Teva Pharmaceuticals Company Detail
        11.16.2 Teva Pharmaceuticals Business Overview
        11.16.3 Teva Pharmaceuticals Semi-Solid Formulations Drug Delivery Introduction
        11.16.4 Teva Pharmaceuticals Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022)
        11.16.5 Teva Pharmaceuticals Recent Development
    11.17 Bristol Myers Squibb
        11.17.1 Bristol Myers Squibb Company Detail
        11.17.2 Bristol Myers Squibb Business Overview
        11.17.3 Bristol Myers Squibb Semi-Solid Formulations Drug Delivery Introduction
        11.17.4 Bristol Myers Squibb Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022)
        11.17.5 Bristol Myers Squibb Recent Development
    11.18 Lead Chemical
        11.18.1 Lead Chemical Company Detail
        11.18.2 Lead Chemical Business Overview
        11.18.3 Lead Chemical Semi-Solid Formulations Drug Delivery Introduction
        11.18.4 Lead Chemical Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022)
        11.18.5 Lead Chemical Recent Development
    11.19 Purdue Pharma
        11.19.1 Purdue Pharma Company Detail
        11.19.2 Purdue Pharma Business Overview
        11.19.3 Purdue Pharma Semi-Solid Formulations Drug Delivery Introduction
        11.19.4 Purdue Pharma Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022)
        11.19.5 Purdue Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Semi-Solid Formulations Drug Delivery Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Creams
    Table 3. Key Players of Ointments
    Table 4. Key Players of Lotions
    Table 5. Key Players of Gel
    Table 6. Key Players of Pastes
    Table 7. Global Semi-Solid Formulations Drug Delivery Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Semi-Solid Formulations Drug Delivery Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Semi-Solid Formulations Drug Delivery Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Semi-Solid Formulations Drug Delivery Market Share by Region (2017-2022)
    Table 11. Global Semi-Solid Formulations Drug Delivery Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Semi-Solid Formulations Drug Delivery Market Share by Region (2023-2028)
    Table 13. Semi-Solid Formulations Drug Delivery Market Trends
    Table 14. Semi-Solid Formulations Drug Delivery Market Drivers
    Table 15. Semi-Solid Formulations Drug Delivery Market Challenges
    Table 16. Semi-Solid Formulations Drug Delivery Market Restraints
    Table 17. Global Semi-Solid Formulations Drug Delivery Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Semi-Solid Formulations Drug Delivery Market Share by Players (2017-2022)
    Table 19. Global Top Semi-Solid Formulations Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Semi-Solid Formulations Drug Delivery as of 2021)
    Table 20. Ranking of Global Top Semi-Solid Formulations Drug Delivery Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Semi-Solid Formulations Drug Delivery Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Semi-Solid Formulations Drug Delivery Product Solution and Service
    Table 24. Date of Enter into Semi-Solid Formulations Drug Delivery Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Semi-Solid Formulations Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Semi-Solid Formulations Drug Delivery Revenue Market Share by Type (2017-2022)
    Table 28. Global Semi-Solid Formulations Drug Delivery Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Semi-Solid Formulations Drug Delivery Revenue Market Share by Type (2023-2028)
    Table 30. Global Semi-Solid Formulations Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Semi-Solid Formulations Drug Delivery Revenue Market Share by Application (2017-2022)
    Table 32. Global Semi-Solid Formulations Drug Delivery Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Semi-Solid Formulations Drug Delivery Revenue Market Share by Application (2023-2028)
    Table 34. North America Semi-Solid Formulations Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Semi-Solid Formulations Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Semi-Solid Formulations Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Semi-Solid Formulations Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Semi-Solid Formulations Drug Delivery Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Semi-Solid Formulations Drug Delivery Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Semi-Solid Formulations Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Semi-Solid Formulations Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Glenmark Pharmaceuticals Company Detail
    Table 45. Glenmark Pharmaceuticals Business Overview
    Table 46. Glenmark Pharmaceuticals Semi-Solid Formulations Drug Delivery Product
    Table 47. Glenmark Pharmaceuticals Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
    Table 48. Glenmark Pharmaceuticals Recent Development
    Table 49. Galderma Company Detail
    Table 50. Galderma Business Overview
    Table 51. Galderma Semi-Solid Formulations Drug Delivery Product
    Table 52. Galderma Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
    Table 53. Galderma Recent Development
    Table 54. Johnson & Johnson Private Company Detail
    Table 55. Johnson & Johnson Private Business Overview
    Table 56. Johnson & Johnson Private Semi-Solid Formulations Drug Delivery Product
    Table 57. Johnson & Johnson Private Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
    Table 58. Johnson & Johnson Private Recent Development
    Table 59. GlaxoSmithKline Company Detail
    Table 60. GlaxoSmithKline Business Overview
    Table 61. GlaxoSmithKline Semi-Solid Formulations Drug Delivery Product
    Table 62. GlaxoSmithKline Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
    Table 63. GlaxoSmithKline Recent Development
    Table 64. Bausch Health Companies Company Detail
    Table 65. Bausch Health Companies Business Overview
    Table 66. Bausch Health Companies Semi-Solid Formulations Drug Delivery Product
    Table 67. Bausch Health Companies Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
    Table 68. Bausch Health Companies Recent Development
    Table 69. Hisamitsu Pharmaceuticals Company Detail
    Table 70. Hisamitsu Pharmaceuticals Business Overview
    Table 71. Hisamitsu Pharmaceuticals Semi-Solid Formulations Drug Delivery Product
    Table 72. Hisamitsu Pharmaceuticals Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
    Table 73. Hisamitsu Pharmaceuticals Recent Development
    Table 74. Cipla Company Detail
    Table 75. Cipla Business Overview
    Table 76. Cipla Semi-Solid Formulations Drug Delivery Product
    Table 77. Cipla Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
    Table 78. Cipla Recent Development
    Table 79. Bayer Company Detail
    Table 80. Bayer Business Overview
    Table 81. Bayer Semi-Solid Formulations Drug Delivery Product
    Table 82. Bayer Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
    Table 83. Bayer Recent Development
    Table 84. Viatris Company Detail
    Table 85. Viatris Business Overview
    Table 86. Viatris Semi-Solid Formulations Drug Delivery Product
    Table 87. Viatris Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
    Table 88. Viatris Recent Development
    Table 89. 3M Company Detail
    Table 90. 3M Business Overview
    Table 91. 3M Semi-Solid Formulations Drug Delivery Product
    Table 92. 3M Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
    Table 93. 3M Recent Development
    Table 94. Merck & Co Company Detail
    Table 95. Merck & Co Business Overview
    Table 96. Merck & Co Semi-Solid Formulations Drug DeliveryProduct
    Table 97. Merck & Co Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
    Table 98. Merck & Co Recent Development
    Table 99. Crescita Therpeautics Company Detail
    Table 100. Crescita Therpeautics Business Overview
    Table 101. Crescita Therpeautics Semi-Solid Formulations Drug DeliveryProduct
    Table 102. Crescita Therpeautics Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
    Table 103. Crescita Therpeautics Recent Development
    Table 104. Novartis International Company Detail
    Table 105. Novartis International Business Overview
    Table 106. Novartis International Semi-Solid Formulations Drug DeliveryProduct
    Table 107. Novartis International Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
    Table 108. Novartis International Recent Development
    Table 109. Boehringer Ingelheim Company Detail
    Table 110. Boehringer Ingelheim Business Overview
    Table 111. Boehringer Ingelheim Semi-Solid Formulations Drug DeliveryProduct
    Table 112. Boehringer Ingelheim Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
    Table 113. Boehringer Ingelheim Recent Development
    Table 114. Pfizer Company Detail
    Table 115. Pfizer Business Overview
    Table 116. Pfizer Semi-Solid Formulations Drug DeliveryProduct
    Table 117. Pfizer Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
    Table 118. Pfizer Recent Development
    Table 119. Teva Pharmaceuticals Company Detail
    Table 120. Teva Pharmaceuticals Business Overview
    Table 121. Teva Pharmaceuticals Semi-Solid Formulations Drug DeliveryProduct
    Table 122. Teva Pharmaceuticals Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
    Table 123. Teva Pharmaceuticals Recent Development
    Table 124. Bristol Myers Squibb Company Detail
    Table 125. Bristol Myers Squibb Business Overview
    Table 126. Bristol Myers Squibb Semi-Solid Formulations Drug DeliveryProduct
    Table 127. Bristol Myers Squibb Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
    Table 128. Bristol Myers Squibb Recent Development
    Table 129. Lead Chemical Company Detail
    Table 130. Lead Chemical Business Overview
    Table 131. Lead Chemical Semi-Solid Formulations Drug DeliveryProduct
    Table 132. Lead Chemical Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
    Table 133. Lead Chemical Recent Development
    Table 134. Purdue Pharma Company Detail
    Table 135. Purdue Pharma Business Overview
    Table 136. Purdue Pharma Semi-Solid Formulations Drug DeliveryProduct
    Table 137. Purdue Pharma Revenue in Semi-Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
    Table 138. Purdue Pharma Recent Development
    Table 139. Research Programs/Design for This Report
    Table 140. Key Data Information from Secondary Sources
    Table 141. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Semi-Solid Formulations Drug Delivery Market Share by Type: 2021 VS 2028
    Figure 2. Creams Features
    Figure 3. Ointments Features
    Figure 4. Lotions Features
    Figure 5. Gel Features
    Figure 6. Pastes Features
    Figure 7. Global Semi-Solid Formulations Drug Delivery Market Share by Application in 2021 & 2028
    Figure 8. Home Care Settings Case Studies
    Figure 9. Hospitals & Clinics Case Studies
    Figure 10. Burn Centers Case Studies
    Figure 11. Other Facilities Case Studies
    Figure 12. Semi-Solid Formulations Drug Delivery Report Years Considered
    Figure 13. Global Semi-Solid Formulations Drug Delivery Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Semi-Solid Formulations Drug Delivery Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Semi-Solid Formulations Drug Delivery Market Share by Region: 2021 VS 2028
    Figure 16. Global Semi-Solid Formulations Drug Delivery Market Share by Players in 2021
    Figure 17. Global Top Semi-Solid Formulations Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Semi-Solid Formulations Drug Delivery as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Semi-Solid Formulations Drug Delivery Revenue in 2021
    Figure 19. North America Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. North America Semi-Solid Formulations Drug Delivery Market Share by Country (2017-2028)
    Figure 21. United States Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Semi-Solid Formulations Drug Delivery Market Share by Country (2017-2028)
    Figure 25. Germany Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Semi-Solid Formulations Drug Delivery Market Share by Region (2017-2028)
    Figure 33. China Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Japan Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. South Korea Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Southeast Asia Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. India Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Australia Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Semi-Solid Formulations Drug Delivery Market Share by Country (2017-2028)
    Figure 41. Mexico Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Brazil Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Semi-Solid Formulations Drug Delivery Market Share by Country (2017-2028)
    Figure 45. Turkey Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Saudi Arabia Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Glenmark Pharmaceuticals Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2017-2022)
    Figure 48. Galderma Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2017-2022)
    Figure 49. Johnson & Johnson Private Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2017-2022)
    Figure 50. GlaxoSmithKline Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2017-2022)
    Figure 51. Bausch Health Companies Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2017-2022)
    Figure 52. Hisamitsu Pharmaceuticals Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2017-2022)
    Figure 53. Cipla Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2017-2022)
    Figure 54. Bayer Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2017-2022)
    Figure 55. Viatris Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2017-2022)
    Figure 56. 3M Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2017-2022)
    Figure 57. Merck & Co Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2017-2022)
    Figure 58. Crescita Therpeautics Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2017-2022)
    Figure 59. Novartis International Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2017-2022)
    Figure 60. Boehringer Ingelheim Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2017-2022)
    Figure 61. Pfizer Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2017-2022)
    Figure 62. Teva Pharmaceuticals Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2017-2022)
    Figure 63. Bristol Myers Squibb Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2017-2022)
    Figure 64. Lead Chemical Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2017-2022)
    Figure 65. Purdue Pharma Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Glenmark Pharmaceuticals
Galderma
Johnson & Johnson Private
GlaxoSmithKline
Bausch Health Companies
Hisamitsu Pharmaceuticals
Cipla
Bayer
Viatris
3M
Merck & Co
Crescita Therpeautics
Novartis International
Boehringer Ingelheim
Pfizer
Teva Pharmaceuticals
Bristol Myers Squibb
Lead Chemical
Purdue Pharma
Frequently Asked Questions
Semi-Solid Formulations Drug Delivery report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Semi-Solid Formulations Drug Delivery report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Semi-Solid Formulations Drug Delivery report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports